European Artificial Intelligence Regulation: Missed Opportunity or Protective Shield

One sector significantly impacted by the use and development of Artificial Intelligence is healthcare and by extension Clinical Research The new Regulation is crucial for AI development as it affects not only technological advancement but also our fundamental rights

Conference in Madrid: “CTIS: full application of the European regulation of clinical trials”

The experts participating in our conference agreed to value the CTIS as a tool that will be very useful for the management of clinical trials in Europe, by harmonizing the requirements among different countries and centralizing documentation management